Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aperion Biologics

Request full access

Clinical-stage medical device company developing a technique to make animal-tissues usable for human applications

San Antonio, United StatesFounded 2008Health Tech & Medtech

About Aperion Biologics

Aperion Biologics, founded in San Antonio, Texas, in 1996, operated as a medical device company focused on creating alternatives to human-based grafts using animal-based tissue technology. The company's core business involved developing cartilage, soft tissue, and bone replacement products. Its primary technology was designed to prevent immunological rejection of animal tissue in human transplantation, offering solutions for patients with ligament issues.

The company's product pipeline included treatments based on this specialized technology aimed at addressing the need for viable tissue grafts. Aperion Biologics went through several funding stages, including grants and venture capital rounds, to finance its research and development efforts. Records show a Series C2 venture round in May 2011. However, the company's journey concluded, and it is now listed as out of business as of December 2017.

It is important to distinguish this San Antonio-based entity from the Vienna, Austria-based APEIRON Biologics AG. APEIRON Biologics AG is an entirely separate company founded in 2003 that specializes in immuno-oncology and was acquired by Ligand Pharmaceuticals in 2024. The two companies, despite the similar names, have distinct histories, founders, and operational focuses.

Source: Dealroom company data

At a glance

Status
Closed
Open positions
None listed
Industry
Health
Sub-industry
Medical Devices
Sector
Biotechnology, Stem Cells, Orthopedic, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Oct 2015 $20M $80M Undisclosed —
SERIES D✓Equity / VC Feb 2013 $770K $3.1M Hasso Plattner Ventures —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Aperion Biologics website traffic

Latest recorded traffic for Aperion Biologics is 290 monthly website visits.

Latest monthly visits290
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
OsteoBiologicsOsteoBiologics engages in the development and manufacture of bioabsorbable polymeric scaffolds, films, and related instrumentations San Antonio, United States Acquired 5,801 $15M $72M
DycareAI-powered telerehabilitation for musculoskeletal and neurological conditions Barcelona, Spain Operational
CollplantRegenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing Ness Ziona, Israel Operational
SINTX TechnologiesSpinal and orthopedic implant company using its silicon nitride ceramic tech to develop spine and total joint implants Salt Lake City, United States Operational
Silicon BiosystemsInnovative technologies and solutions for isolation, recovery & molecular characterization of pure, single rare cells. Bologna, Italy Acquired
Spinal SimplicitySpinal Simplicity develops and distributes percutaneously-inserted inter-laminar fusion devices for the treatment of spinal problems Overland Park, United States Operational
OrthoSpaceInnovative balloon technology for rapid rotator cuff repair, minimizing surgery time and enhancing recovery Caesarea, Israel Acquired
NLT SPINEDevelops and markets medical devices (implants and instruments) intended for the surgical treatment of back pain Kfar Saba, Israel Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Aperion Biologics in the San Antonio ecosystem

Live from Dealroom

The Aperion Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • Deutsche Bank
  • Lurie Investment Fund
  • Hasso Plattner Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Antonio HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aperion Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aperion Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.